Sifalimumab is a fully human monoclonal antibody targeting interferon-alpha, potentially suppressing abnormal immune activity in lupus by binding to multiple interferon-alpha subtypes. The DrugMonitor™ Anti-Sifalimumab Antibody (VS-1224-YC1087) is an anti-drug antibody (ADA) against Sifalimumab. This drug-based antibody is raised in mice immunized with the Sifalimumab. The anti-Sifalimumab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Sifalimumab in samples.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Anti-Human IFNA1 Recombinant Antibody (Sifalimumab)Recombinant human antibody to Human IFNA1. Sifalimumab is a human monoclonal antibody designed for the treatment of SLE, dermatomyositis, and polymyositis.
Afuco™ Anti-IFNA1 ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-H62)This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant human antibody to Human IFNA1. It is a human monoclonal antibody designed for the treatment of SLE, dermatomyositis, and polymyositis.
There are currently no Customer reviews or questions for VS-1224-YC1087. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.